Brief: Alligator Bioscience Announces Trial Update

Alligator Bioscience AB

16/12/2021 07:05

Dec 16 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR BIOSCIENCE ANNOUNCES TRIAL UPDATE AND EARLY
READOUT
FOR ATOR-1017 CONFIRMING BIOMARKER, SAFETY & TOLERABILITY DATA
    * EARLY READOUT DATA CORROBORATES PREVIOUS DATA ON
BIOMARKERS,
SAFETY AND TOLERABILITY, SUSTAINING A SAFETY PROFILE UP TO AND
INCLUDING A DOSE OF 360 MG WITH NO DOSE LIMITING TOXICITIES
REPORTED.

Source text for Eikon:  ID:nWkrhZDYL 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))